|
Volumn 13, Issue 452, 1999, Pages 390-395
|
When is it necessary to treat dysthyroidism in the initial phase?;Dysthyroidies frustes: Quand faut-il traiter?
a a |
Author keywords
[No Author keywords available]
|
Indexed keywords
AMIODARONE;
AMPHETAMINE;
APOMORPHINE;
BROMOCRIPTINE MESILATE;
CIMETIDINE;
CITALOPRAM;
DOPAMINE RECEPTOR STIMULATING AGENT;
DOPERGINE;
FLUMACH;
FLUOXETINE;
FLUVOXAMINE MALEATE;
HIGH DENSITY LIPOPROTEIN CHOLESTEROL;
INTERFERON;
LEVOTHYROXINE;
LITHIUM;
LOW DENSITY LIPOPROTEIN CHOLESTEROL;
NEUROLEPTIC AGENT;
PAROXETINE;
PIRIBEDIL;
POVIDONE IODINE;
ROPINIROLE;
SERTRALINE;
SPIRONOLACTONE;
TRIACYLGLYCEROL;
UNCLASSIFIED DRUG;
CHOLESTEROL BLOOD LEVEL;
DECISION MAKING;
DISEASE CLASSIFICATION;
DRUG CROSS REACTIVITY;
EARLY DIAGNOSIS;
HEART ATRIUM FIBRILLATION;
HUMAN;
HUMAN TISSUE;
HYPERTHYROIDISM;
HYPOTHYROIDISM;
PATHOPHYSIOLOGY;
SHORT SURVEY;
THYROID SCINTISCANNING;
TREATMENT INDICATION;
|
EID: 0033535428
PISSN: 09892737
EISSN: None
Source Type: Journal
DOI: None Document Type: Short Survey |
Times cited : (3)
|
References (10)
|